About: SULINDAC IN OSTEOARTHROSIS OF THE HIP

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : SULINDAC IN OSTEOARTHROSIS OF THE HIP Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/oup/periodical/brheum/1976/volume_15/issue_2/w
Subject	ORIGINAL PAPERS
Title	SULINDAC IN OSTEOARTHROSIS OF THE HIP
has manifestation of work	http://hub.abes.fr/oup/periodical/brheum/1976/volume_15/issue_2/101093rheumatology152112/m/web http://hub.abes.fr/oup/periodical/brheum/1976/volume_15/issue_2/101093rheumatology152112/m/print
related by	http://hub.abes.fr/oup/periodical/brheum/1976/volume_15/issue_2/101093rheumatology152112/authorship/3 http://hub.abes.fr/oup/periodical/brheum/1976/volume_15/issue_2/101093rheumatology152112/authorship/1 http://hub.abes.fr/oup/periodical/brheum/1976/volume_15/issue_2/101093rheumatology152112/authorship/4 http://hub.abes.fr/oup/periodical/brheum/1976/volume_15/issue_2/101093rheumatology152112/authorship/2
Author	PERERA T. DIEPPE P. A. BURRY H. C. GRAHAME R.
Abstract	SUMMARY. Sulindac (400 mg/day) has been compared with ibuprofen (1200 mg/day) in 40 patients with osteoarthrosis of the hip, over an eight-week period, in a double-blind controlled clinical trial. The two drugs were comparable in terms of patient preference, effects on hip movements, and toxicity. Sulindac showed superior analgesic properties to ibuprofen, resulting in a significantly greater reduction in pain on weight-bearing and with passive movements P<0.01).
article type	other
publisher identifier	15.2.112
is part of this journal	Rheumatology

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata